GE and R2 extend partnership
The first company to commercialize a full-field digital mammography system and the first to deliver mammography CAD have renewed their alliance. GE Medical Systems (Waukesha, WI) and R2 Technology (Sunnyvale, CA) announced Dec. 12 that R2's ImageChecker
The first company to commercialize a full-field digital mammography system and the first to deliver mammography CAD have renewed their alliance. GE Medical Systems (Waukesha, WI) and R2 Technology (Sunnyvale, CA) announced Dec. 12 that R2's ImageChecker CAD system would continue to be distributed with GE's Senographe 2000D full-field digital mammography system. More than 100 such combinations are already operating in clinical sites, according to GE, and there is room for substantial growth. More than 550 Senographe 2000D systems have been installed in the U.S., and all are upgradable to R2's CAD technology. The FDA originally cleared the ImageChecker system in 1998 for use with film-based screening mammography to assist radiologists in minimizing false-negative readings. Supplemental approvals by the FDA allowed the technology to be used in combination with the Senographe 2000D.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
